Moderna's coronavirus COVID-19 vaccine shows promising results in human safety trial, shares soar
Moderna Inc said on Monday its experimental COVID-19 vaccine showed promise in a small early-stage trial, with the vaccine producing virus-neutralizing antibodies similar to that found in recovered patients, sending shares soaring 25%.
May 18, 2020, 19:16 PM IST